Radiofrequency Ablation of Primary and Metastatic Lung Cancers

Seminars in Ultrasound, CT and MRI

Volumn 30, Issue 2, 2009, Pages 113-124

  Pua, Bradley B ^a   Solomon, Stephen B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL EXAMINATION; FLUOROSCOPY; HISTOPATHOLOGY; HUMAN; LUNG CANCER; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; ULTRASOUND;

ANIMALS; CATHETER ABLATION; HUMANS; IMAGING, THREE-DIMENSIONAL; LUNG NEOPLASMS; PATIENT CARE PLANNING; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; RADIOGRAPHY, INTERVENTIONAL; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 61349145135     PISSN: 08872171     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sult.2008.12.001     Document Type: Article

References (58)

1. Curley S.A., Izzo F., Delrio P., et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: Results in 123 patients. Ann Surg 230 1 (1999) 1-8
2. Dupuy D.E., Zagoria R.J., Akerley W., et al. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol 174 1 (2000) 57-59
3. American Cancer Society: Cancer Facts and Figures 2008 (2008), American Cancer Society, Atlanta, GA
4. Ginsberg R.J., and Rubinstein L.V. Randomized trial of lobectomy versus limited resection for T1 N0 nonsmall cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 60 (1995) 615-622
5. Mery C.M., Pappas A.N., Bueno R., et al. Similar long-term survival of elderly patients with nonsmall cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest 128 1 (2005) 237-245
6. Bilfinger T.V., and Baram D. Sublobar resection in nonsmall cell lung carcinoma. Curr Opin Pulm Med 14 4 (2008) 292-296
7. Decker R.H., Tanoue L.T., Colasanto J.M., et al. Evaluation and definitive management of medically inoperable early stage nonsmall-cell lung cancer. Part 2: Newer treatment modalities. Oncology 20 8 (2006) 899-905
8. McCormack P.M., and Ginsberg R.J. Current management of colorectal metastases to lung. Chest Surg Clin North Am 8 1 (1998) 119-126
9. The International Registry of Lung Metastases: Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases. J Thorac Cardiovascular Surg 113 1 (1997) 37-49
10. Goldberg S.N., Gazelle G.S., and Mueller P.R. Thermal ablation therapy for focal malignancy: A unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 174 2 (2000) 323-331
11. Goldberg S.N., and Dupuy D.E. Image-guided radiofrequency tumor ablation: Challenges and opportunities-Part I. J Vasc Interv Radiol 12 9 (2001) 1021-1032
12. Goldberg S.N., Ahmed M., Gazelle G.S., et al. Radio-frequency thermal ablation with NaCl solution injection: Effect of electrical conductivity on tissue heating and coagulation-phantom and porcine liver study. Radiology 219 1 (2001) 157-165
13. Ahmed M., Liu Z., Afzal K.S., et al. Radiofrequency ablation: Effect of surrounding tissue composition on coagulation necrosis in a canine tumor model. Radiology 230 3 (2004) 761-767
14. Lu D.S., Raman S.S., Limanond P., et al. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol 14 10 (2003) 1267-1274
15. de Baere T., Denys A., Wood B.J., et al. Radiofrequency liver ablation: Experimental comparative study of water-cooled versus expandable systems. AJR Am J Roentgenol 176 1 (2001) 187-192
16. Lin S.M., Lin C.J., Chung H.J., et al. Power rolloff during interactive radiofrequency ablation can enhance necrosis when treating hepatocellular carcinoma. AJR Am J Roentgenol 180 1 (2003) 151-157
17. Boehm T., Malich A., Goldberg S.N., et al. Radio-frequency tumor ablation: Internally cooled electrode versus saline-enhanced technique in an aggressive rabbit tumor model. Radiology 222 3 (2002) 805-813
18. Kim S.K., Gu M.S., Hong H.P., et al. CT findings after radiofrequency ablation in rabbit livers: Comparison of internally cooled electrodes, perfusion electrodes, and internally cooled perfusion electrodes. J Vasc Interv Radiol 18 11 (2007) 1417-1427
19. Chinn S.B., Lee Jr. F.T., Kennedy G.D., et al. Effect of vascular occlusion on radiofrequency ablation of the liver: Results in a porcine model. AJR Am J Roentgenol 176 3 (2001) 789-795
20. Lin S.M., Lin C.C., Chen W.T., et al. Radiofrequency ablation for hepatocellular carcinoma: A prospective comparison of four radiofrequency devices. J Vasc Interv Radiol 18 9 (2007) 1118-1125
21. Hiraki T., Sakurai J., Tsuda T., et al. Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors: Evaluation based on a preliminary review of 342 tumors. Cancer 107 12 (2006) 2873-2880
22. Tominaga J., Miyachi H., Takase K., et al. Time-related changes in computed tomographic appearance and pathologic findings after radiofrequency ablation of the rabbit lung: Preliminary experimental study. J Vasc Interv Radiol 16 12 (2005) 1719-1726
23. Oyama Y., Nakamura K., Matsuoka T., et al. Radiofrequency ablated lesion in the normal porcine lung: Long-term follow-up with MRI and pathology. Cardiovascular Interv Radiol 28 3 (2005) 346-353
24. Morrison P.R., vanSonnenberg E., Shankar S., et al. Radiofrequency ablation of thoracic lesions. Part 1. Experiments in the normal porcine thorax. AJR Am J Roentgenol 184 2 (2005) 375-380
25. Nomori H., Imazu Y., Watanabe K., et al. Radiofrequency ablation of pulmonary tumors and normal lung tissue in swine and rabbits. Chest 127 3 (2005) 973-977
26. Goldberg S.N., Gazelle G.S., Compton C.C., et al. Radio-frequency tissue ablation of VX2 tumor nodules in the rabbit lung. Acad Radiol 3 11 (1996) 929-935
27. Miao Y., Ni Y., Bosmans H., et al. Radiofrequency ablation for eradication of pulmonary tumor in rabbits. J Surg Res 99 2 (2001) 265-271
28. Okuma T., Matsuoka T., Okamura T., et al. 18F-FDG small-animal PET for monitoring the therapeutic effect of CT-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits. J Nucl Med 47 8 (2006) 1351-1358
29. Herrera L.J., Fernando H.C., Perry Y., et al. Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates. J Thorac Cardiovascular Surg 125 4 (2003) 929-937
30. Suh R.D., Wallace A.B., Sheehan R.E., et al. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation-Preliminary results. Radiology 229 3 (2003) 821-829
31. Lee J.M., Jin G.Y., Goldberg S.N., et al. Percutaneous radiofrequency ablation for inoperable nonsmall cell lung cancer and metastases: Preliminary report. Radiology 230 1 (2004) 125-134
32. Yasui K., Kanazawa S., Sano Y., et al. Thoracic tumors treated with CT-guided radiofrequency ablation: Initial experience. Radiology 231 3 (2004) 850-857
33. Akeboshi M., Yamakado K., Nakatsuka A., et al. Percutaneous radiofrequency ablation of lung neoplasms: Initial therapeutic response. J Vasc Interv Radiol 15 5 (2004) 463-470
34. Gadaleta C., Mattioli V., Colucci G., et al. Radiofrequency ablation of 40 lung neoplasms: Preliminary results. AJR Am J Roentgenol 183 2 (2004) 361-368
35. Belfiore G., Moggio G., Tedeschi E., et al. CT-guided radiofrequency ablation: A potential complementary therapy for patients with unresectable primary lung cancer-A preliminary report of 33 patients. AJR Am J Roentgenol 183 4 (2004) 1003-1011
36. VanSonnenberg E., Shankar S., Morrison P.R., et al. Radiofrequency ablation of thoracic lesions. Part 2. Initial clinical experience-Technical and multidisciplinary considerations in 30 patients. AJR Am J Roentgenol 184 2 (2005) 381-390
37. Fernando H.C., De Hoyos A., Landreneau R.J., et al. Radiofrequency ablation for the treatment of nonsmall cell lung cancer in marginal surgical candidates. J Thorac Cardiovascular Surg 129 3 (2005) 639-644
38. Bojarski J.D., Dupuy D.E., and Mayo-Smith W.W. CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: Results in 32 tumors. AJR Am J Roentgenol 185 2 (2005) 466-471
39. Ambrogi M.C., Lucchi M., Dini P., et al. Percutaneous radiofrequency ablation of lung tumours: Results in the mid-term. Eur J Cardiothorac Surg 30 1 (2006) 177-183
40. de Baere T., Palussiere J., Auperin A., et al. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: Prospective evaluation. Radiology 240 2 (2006) 587-596
41. Lagana D., Carrafiello G., Mangini M., et al. Radiofrequency ablation of primary and metastatic lung tumors: Preliminary experience with a single center device. Surg Endosc 20 8 (2006) 1262-1267
42. Pennathur A., Luketich J.D., Abbas G., et al. Radiofrequency ablation for the treatment of stage I nonsmall cell lung cancer in high-risk patients. J Thorac Cardiovascular Surg 134 4 (2007) 857-864
43. Hiraki T., Gobara H., Iishi T., et al. Percutaneous radiofrequency ablation for clinical stage I nonsmall cell lung cancer: Results in 20 nonsurgical candidates. J Thorac Cardiovascular Surg 134 5 (2007) 1306-1312
44. Lencioni R., Crocetti L., Cioni R., et al. Response to radiofrequency ablation of pulmonary tumours: A prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 9 7 (2008) 621-628
45. King J., Glenn D., and Clark W. Percutaneous radiofrequency ablation of pulmonary metastases in patients with colorectal cancer. Br J Surg 91 2 (2004) 217-223
46. Livraghi T., Solbiati L., Meloni F., et al. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: The "test-of-time approach". Cancer 97 12 (2003) 3027-3035
47. Rose S.C., Thistlethwaite P.A., and Sewell P.E. Lung cancer and radiofrequency ablation. J Vasc Interv Radiol 17 6 (2006) 927-951
48. Ambrogi M.C., Fanucchi O., Lencioni R., et al. Pulmonary radiofrequency ablation in a single lung patient. Thorax 61 9 (2006) 828-829
49. Hayes D.L., Charboneau J.W., Lewis B.D., et al. Radiofrequency treatment of hepatic neoplasms in patients with permanent pacemakers. Mayo Clin Proc 76 (2001) 950-952
50. Solomon S.B., Thornton R.H., Dupuy D.E., et al. Protection of the mediastinum and chest wall with an artificial pneumothorax during lung ablations. J Vasc Interv Radiol 19 4 (2008) 610-615
51. Shankar S., Vansonnenberg E., Silverman S.G., et al. Brachial plexus injury from CT-guided RF ablation under general anesthesia. Cardiovasc Intervent Radiol 28 5 (2005) 646-648
52. Air Transport Medicine Committee, Aerospace Medical Association: Medical guidelines for Air travel. Aviat Space Environ Med 67 suppl (1996) Bl-B8
53. Cheatham M.L., and Safcsak K. Air travel following traumatic pneumothorax: When is it safe?. Am Surg 65 12 (1999) 1160-1164
54. Okuma T., Matsuoka T., Yamamoto A., et al. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors. Cardiovasc Interv Radiol 31 1 (2008) 122-130
55. Nguyen C.L., Scott W.J., and Goldberg M. Radiofrequency ablation of lung malignancies. Ann Thorac Surg 82 1 (2006) 365-371
56. Nguyen C.L., Scott W.J., Young N.A., et al. Radiofrequency ablation of primary lung cancer: Results from an ablate and resect pilot study. Chest 128 5 (2005) 3507-3511
57. Yamagami T., Kato T., Hirota T., et al. Risk factors for occurrence of local tumor progression after percutaneous radiofrequency ablation for lung neoplasms. Diagn Interv Radiol 13 4 (2007) 199-203
58. Steinke K., Haghighi K.S., Wulf S., et al. Effect of vessel diameter on the creation of ovine lung radiofrequency lesions in vivo: Preliminary results. J Surg Res 124 1 (2005) 85-91